Viewing Study NCT02502903


Ignite Creation Date: 2025-12-24 @ 7:48 PM
Ignite Modification Date: 2026-04-18 @ 5:16 AM
Study NCT ID: NCT02502903
Status: COMPLETED
Last Update Posted: 2022-04-25
First Post: 2015-07-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Tolerability and Activity of BIVV009 in Healthy Volunteers and Patients With Complement Mediated Disorders
Sponsor: Bioverativ, a Sanofi company
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Bullous Pemphigoid (BP) View
None Cold Agglutinin Disease (CAD) View
None Warm Autoimmune Hemolytic Anemia (WAIHA) View
None End-stage Renal Disease (ESRD) View
Keywords: